Duffy Sean P. 4
4 · Omada Health, Inc. · Filed Jul 6, 2026
Research Summary
AI-generated summary of this filing
Omada Health (OMDA) CEO Sean Duffy Exercises Options, Sells Shares
What Happened
Sean P. Duffy, CEO of Omada Health, exercised stock options and sold the resulting shares in the open market on July 1, 2026. He exercised 12,944 options at $5.82 (cost $75,334) and 12,942 options at $8.28 (cost $107,160), and sold those shares: 12,944 shares at a weighted average $22.70 (proceeds $293,787) and 12,942 shares at a weighted average $22.67 (proceeds $293,435). Total proceeds from the sales were about $587,222; total option exercise cost was about $182,494, for net proceeds of roughly $404,728 before fees and taxes. The filing also shows two derivative conversion/disposition entries at $0 for the same share amounts (common in option conversion/net-settlement reporting).
Key Details
- Transaction date: July 1, 2026 (filed July 6, 2026). Filing was 5 days after the transactions (later than the typical 2-business-day Form 4 deadline).
- Sales executed in multiple trades; weighted-average sale prices reflect ranges of $22.23–$23.04 and $22.095–$22.95 (see footnotes).
- Shares acquired via exercise: 25,886 total (12,944 + 12,942); shares sold in open market: 25,886 total.
- Option exercise costs: ~$182,494; gross sale proceeds: ~$587,222; approximate net before tax/fees: ~$404,728.
- Footnotes: 10b5-1 trading plan adopted March 13, 2026 (F1); option shares are 100% vested (F5); some shares held in family trusts (F4).
- Shares owned after the transaction: not specified in the filing.
Context
- This was an exercise of vested options followed by open-market sales — effectively a cash-in event for the CEO rather than an additional purchase of company stock. The $0 derivative disposal lines likely reflect conversion/net settlement mechanics commonly reported when exercising options.
- The trades were executed under a pre-established 10b5-1 plan, which is designed to allow scheduled insider sales and reduce timing concerns; filings should still meet the SEC’s 2-business-day reporting window (this one was filed later).
- Facts only — this report documents the transactions and does not state the CEO’s motivations.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-07-01$5.82/sh+12,944$75,334→ 424,805 total - Sale
Common Stock
[F1][F2]2026-07-01$22.70/sh−12,944$293,787→ 411,861 total - Exercise/Conversion
Common Stock
2026-07-01$8.28/sh+12,942$107,160→ 424,803 total - Sale
Common Stock
[F1][F3]2026-07-01$22.67/sh−12,942$293,435→ 411,861 total - Exercise/Conversion
Stock Option (Right to Buy)
[F5]2026-07-01−12,944→ 155,427 totalExercise: $5.82Exp: 2029-08-21→ Common Stock (12,944 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F5]2026-07-01−12,942→ 116,077 totalExercise: $8.28Exp: 2031-05-05→ Common Stock (12,942 underlying)
- 851,659(indirect: See footnote)
Common Stock
[F4]
Footnotes (5)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- [F2]This transaction was executed in multiple trades at prices ranging from $22.23 to $23.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $22.095 to $22.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
- [F5]100% of the shares subject to the option are fully vested and exercisable.